Conference Proceedings

A 3-ARM, PHASE IIA TRIAL OF SAFETY & EFFICACY OF OLINVACIMAB, A MONOCLONAL ANTIBODY TO VEGFR2 IN PATIENTS WITH RECURRENT GLIOBLASTOMA MULTIFORME WITH IMAGING AND PK/PD ASSESSMENTS: FINAL REPORT

Lawrence Cher, Anna Nowak, George Iatropoulos, Samantha Bowyer, Hui Gan, Anne Poh Long, Michael Bynevelt, Graeme Jackson, Seon Young Lee, Weon Sup Lee, Jin-San Yoo

NEURO-ONCOLOGY | OXFORD UNIV PRESS INC | Published : 2020